Thapar P, Zacny J P, Choi M, Apfelbaum J L
Department of Anesthesia and Critical Care, University of Chicago, IL 60637, USA.
Anesth Analg. 1995 Jun;80(6):1092-8. doi: 10.1097/00000539-199506000-00005.
Impairment caused by different sedative/analgesic combinations commonly used in ambulatory settings was compared to that of alcohol at blood alcohol concentrations (BACs) higher than or equal to 0.10%. Impairment was measured via subjective (mood) and objective (psychomotor performance) assays. Twelve healthy human volunteers (10 males and 2 females; age range 21-34 yr) participated in this prospective, double-blind, randomized, cross-over study. Each subject was exposed to five drug conditions across 5 wk. Each of the following drug conditions were adjusted for body weight (per 70 kg):fentanyl 50 micrograms and propofol 35 mg (FP), fentanyl 50 micrograms and midazolam 2 mg (FM), fentanyl 50 micrograms, midazolam 2 mg, and propofol 35 mg (FMP), alcohol 56 g (orally administered), and placebo (PLC). With the exception of alcohol, the other drugs were administered via the intravenous route. Tests for psychomotor performance, subjective effects, and short-term memory were done at baseline, and at different intervals until 240 min postinjection. Psychomotor impairment caused by alcohol at 15 min postingestion (at a BAC of 0.11% +/- 0.03% [mean +/- SE]) was used as a benchmark with which impairment caused by other sedative/analgesic combinations was compared. All the study drug combinations produced impairment (i.e., impairment greater than that seen with PLC), similar to that observed with alcohol at a BAC of 0.11%. We have demonstrated that some sedative/analgesic drug combinations used in anesthesia for ambulatory procedures produce impairment similar to or greater than that observed with a large dose of alcohol.
将门诊环境中常用的不同镇静/镇痛药物组合所导致的功能损害,与血液酒精浓度(BAC)高于或等于0.10%时酒精所导致的功能损害进行了比较。通过主观(情绪)和客观(心理运动表现)测定来衡量功能损害。12名健康人类志愿者(10名男性和2名女性;年龄范围21 - 34岁)参与了这项前瞻性、双盲、随机、交叉研究。每位受试者在5周内接受五种药物情况的测试。以下每种药物情况均根据体重(每70千克)进行调整:芬太尼50微克和丙泊酚35毫克(FP)、芬太尼50微克和咪达唑仑2毫克(FM)、芬太尼50微克、咪达唑仑2毫克和丙泊酚35毫克(FMP)、酒精56克(口服)以及安慰剂(PLC)。除酒精外,其他药物均通过静脉途径给药。在基线以及注射后不同时间间隔直至240分钟,进行心理运动表现、主观效应和短期记忆测试。将摄入酒精后15分钟(BAC为0.11%±0.03%[均值±标准误])时酒精所导致的心理运动损害作为基准,与其他镇静/镇痛药物组合所导致的损害进行比较。所有研究药物组合均产生了功能损害(即,损害程度大于PLC组),类似于BAC为0.11%时酒精所观察到的损害。我们已经证明,门诊手术麻醉中使用的一些镇静/镇痛药物组合所产生的损害,与大剂量酒精所观察到的损害相似或更大。